
April 3 (Reuters) - Abbvie Inc ABBV.N:
Q1 2025 EARNINGS INCLUDE $248 MILLION IPR&D AND MILESTONES EXPENSE - SEC FILING
SEES FOR Q1 UNFAVORABLE IMPACT OF $0.13 TO GAAP AND NON-GAAP EPS - SEC FILING
Q1 2025 ADJUSTED EPS GUIDANCE $2.34 - $2.38 - SEC FILING
FULL-YEAR 2025 ADJUSTED EPS GUIDANCE $11.99 - $12.19 - SEC FILING
Q1 EARNINGS PER SHARE VIEW $2.51 -- LSEG IBES DATA
FY2025 EARNINGS PER SHARE VIEW $12.30 -- LSEG IBES DATA
Source text: [ID:n0001551152-25-000023]
Further company coverage: ABBV.N